CYAD

Celyad Oncology SA American Depositary Shares

Delisted

CYAD was delisted on the 18th of May, 2023.

12 hedge funds and large institutions have $21.4M invested in Celyad Oncology SA American Depositary Shares in 2018 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
4
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Victory Capital Management
1
Victory Capital Management
Texas
$18.7M +$5.53M +178,380 +42%
SLG
2
Stanley-Laman Group
Pennsylvania
$1.15M +$1.15M +38,525 New
Millennium Management
3
Millennium Management
New York
$582K +$582K +18,781 New
EP
4
Eversept Partners
New York
$382K +$382K +12,840 New
Renaissance Technologies
5
Renaissance Technologies
New York
$205K +$10.1K +340 +5%
Deutsche Bank
6
Deutsche Bank
Germany
$181K +$31.3K +1,058 +21%
Morgan Stanley
7
Morgan Stanley
New York
$70K -$113K -3,790 -62%
UBS Group
8
UBS Group
Switzerland
$54K +$10.4K +351 +24%
Wells Fargo
9
Wells Fargo
California
$15K +$15K +500 New
Zurich Cantonal Bank
10
Zurich Cantonal Bank
Switzerland
$3K
Bank of Montreal
11
Bank of Montreal
Ontario, Canada
$3K
US Bancorp
12
US Bancorp
Minnesota
$2K +$2K +79 New
Jane Street
13
Jane Street
New York
-$586K -16,816 Closed
TRCT
14
Tower Research Capital (TRC)
New York
-$1K -32 Closed